Phase 2 T Lymphoblastic Leukemia/Lymphoma Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Venetoclax and Decitabine in R/R T-ALL

T Lymphoblastic Leukemia/Lymphoma

Seoul National University Hospital28 enrolled3 locationsNCT06712121

Recruiting

Phase 1Phase 2

SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Acute Myeloid Leukemia (AML)T Lymphoblastic Leukemia/Lymphoma

Institute of Hematology & Blood Diseases Hospital, China12 enrolled1 locationNCT07153068

Recruiting

Phase 2

PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma

PersonGen BioTherapeutics (Suzhou) Co., Ltd.100 enrolled15 locationsNCT07188610